Novo Nordisk's (NOVOB DC) CagriSema demonstrated superior HbA1c reduction of 1.91%-points and weight loss of 14.2% in adults with type 2 diabetes in the REIMAGINE 2 Trial
Newsquawk Staff ·
Novo Nordisk's (NOVOB DC) CagriSema demonstrated superior HbA1c reduction of 1.91%-points and weight loss of 14.2% in adults with type 2 diabetes in the REIMAGINE 2 Trial.
What it means
Novo Nordisk's latest trial results for CagriSema indicate a significant improvement in HbA1c reduction and weight loss for adults with type 2 diabetes. This strong performance could bolster the company's position in the diabetes treatment market, potentially attracting greater investor interest and impacting their stock positively, especially if future guidance reflects these outcomes.
Sources
- Lufthansa (LHA GY) and the Portuguese government sign agreement for acquisition of a minority stake in Tap Air Portugal, with the deal valued at EUR 1.2bln
- Ferrari (RACE IM) CEO says they are very satisfied with Luce EV, with no critical issues on the production or demand side; Co. is working on next EV models
- Intesa Sanpaolo (ISP IM) Q3 2026 (EUR): Revenue 6.92bln (exp. 7bln), Net Income 2.54bln (exp. 2.50bln), NII 3.89bln (exp. 3.9bln); announces interim dividends of EUR 3.8bln
- Ferrari (RACE IM) Q3 2026 (EUR): Revenue 1.9bln (exp. 1.89bln), EPS 2.44 (exp. 2.38); raises FY26 EPS to "more than" 9.85 (exp. 9.93, prev. "more than" 9.68)
- German Chancellor Merz calls for further cuts in air traffic tax
Related headlines
- EUROPEAN OPEN: AAPL falls on margin outlook; NVDA tells partners to limit China exposure; BAYN GY raises FY26 EBITDA view; PHIA NA Q3 beat; fuel costs hit LHA GY FY26 EBIT view; Aramco net profit +35%; SHEL LN sells North West Shelf stakes for USD 1.45bln5 days ago
- European Movers: Coloplast (COLOB DC) -5%, Alstom (ALO FP) -4%, Zalando (ZAL GY) -3%, Philips (PHIA NA) +6.2%, Drax (DRX LN) +8%5 days ago
- Additional European Equity News - 3rd November 20265 days ago
- European Pre-Market Summary 3rd November 2026: European bourses set for a weak open amidst Iranian diplomacy pushback; BAYN GY reports strong results and lifts guidance5 days ago
- Newsquawk Daily European Equity Opening News - 3rd November 20265 days ago
- Grifols (GRF SM) Q3 2026 (EUR): Revenue 2.04bln (exp. 1.97bln); Net income 162mln; Adj. EBITDA 538mln (exp. 515.8mln)6 days ago
- Intesa Sanpaolo (ISP IM) reportedly plans to start its bid for BMPS (BMPS IM) on the week of November 23, Bloomberg reports6 days ago
- Ahold Delhaize's (AD NA) refrigerators and freezers in dozens of supermarkets in Belgium and Luxembourg were hit by an "IT incident"6 days ago
- Maersk (MAERSKB DC) announces that, with Hapag-Lloyd (HLAG GY), it will be rerouting vessels via the Suez Canal instead of the Cape of Good Hope, effective November 4th and 13th6 days ago
- EUROPEAN OPEN: FRE GY secures options for 37 WuXi biosimilars; BoE mulls easing mortgage rules; RYA ID plans cost cuts as fuel costs rise; BP/ LN completes Castrol stake sale for USD 6bln; TTE FP acquires 30% interest in Malaysian gas fields; ALO FP cuts 6 days ago
- European Movers: Alstom (ALO FP) -24%, Bakkafrost (BAKKA NO) -5.3%, Novartis (NOVN SW) -2%, Ryanair (RYA ID) -0.3% 6 days ago
- Additional European Equity News - 2nd November 20266 days ago
- European Pre-Market Summary 2nd November 2026: European bourses set for a slightly firmer open; Ryanair tops expectations but profit falls amidst higher fuel costs6 days ago
- Newsquawk Daily European Equity Opening News - 2nd November 20266 days ago
- EUROPEAN OPEN: EVK GY reportedly to reject BAS GY EUR offer; BAYN GY wins St. Louis Roundup trial; AZN LN, SAN FP beats; ACA FP net income misses; NWG LN revenue miss, PBT beat; BP/ LN earnings top expectationsOct 30